SEC Form D private-offering filing

Telos Biotech Inc.

Name: Telos Biotech Inc. - new SEC Form D private-offering filing, Dallas, TX
Published: 2025-12-12

A new SEC Form D private-offering notice from Dallas, TX, a $2,250,000 filer-stated offering target in Biotech. The source filing is one click away.

Telos Biotech Inc. site↗ Verified via SEC Form D

Develops Telovance, a protein complex delivered during cell therapy manufacturing to lengthen shortened telomeres and improve the durability of engineered cells.

Filed 2025-12-12Filed to raise $2,250,000First money in 2025-12-01Raised so far $724,999HQ (as filed) Dallas, TXSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified telosbio.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.